Assessing the Impact of Chronic Obstructive Pulmonary Disease on Severity of Silent Myocardial Ischemia in Patients with Arterial Hypertension-Reference-Cited by-同舟云学术

Assessing the Impact of Chronic Obstructive Pulmonary Disease on Severity of Silent Myocardial Ischemia in Patients with Arterial Hypertension

Published:2024-07-04 Issue:3 Volume:102 Page:12-17
ISSN:2542-1506
Container-title:Tuberculosis and Lung Diseases
language:
Short-container-title:Tuberk. bolezni lëgk.

Author:

Tayutina T. V.¹,Kudlay D. A.²,Shovkun L. A.¹,Nikolenko N. Yu.³,Kampos E. D.¹

Affiliation:

1. Rostov State Medical University, Russian Ministry of Health

2. I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; Lomonosov Moscow State University; Immunology Research Institute by the Russian Federal Medical Biological Agency

3. Moscow Research and Clinical Center for Tuberculosis Control, Moscow Health Department

Abstract

The objective: to evaluate the effect of chronic obstructive pulmonary disease on the severity of silent myocardial ischemia in patients with arterial hypertension.Subjects and Methods. Examinations and follow-up of 194 COPD patients who were undergoing outpatient follow-up and treatment were analyzed. Those patients suffered from COPD with concurrent arterial hypertension or isolated arterial hypertension.Results. Holter ECG monitoring should be done in all COPD patients regardless of severity of the disease and presence of comorbid conditions. This is due to the high prevalence of silent myocardial ischemia in such patients.

Publisher

LLC "Medical Knowledge and Technologies"

Reference8 articles.

1. Kuznetsov A.N., Grigorieva N.Yu., Ilyushina T.P., Mayorova M.V. Is there a relationship between bronchial asthma and arterial hypertension? Terapiya, 2017, vol. 1, no. 11, pp. 60-64. (In Russ.)

2. Nevzorova V.A., Zakharchuk N.V., Brodskaya T.A. et al. Evaluation of cardiovascular risk in chronic obstructive pulmonary disease using spirometry indices. Siberian Medical Review, 2018, vol. 110, no. 2, pp. 18-24. (In Russ.) https://doi.org/10.20333/2500136-2018-2-18-24

3. Oganov R.G., Denisov I.N., Simanenkov V.I. et al. Comorbid pathology in clinical practice (guidelines). Kardiovaskulyarnaya Terapiya i Profilaktika, 2017, vol. 17, no. 6, pp. 5-56. (In Russ.)

4. Poliklinicheskaya Terapiya. Uchebnik. [Polyclinic therapy. Handbook]. D.I. Davydkin, Yu.V. Schukin, eds., 2nd ed., suppl. and amend., Moscow, GEOTAR-Media Publ., 2020, 840 p.

5. Khasanov A.Kh., Bakirov B.A., Davletshin R.A. et al. Impact of endothelial dysfunction on gender-specific vascular and neurocognitive heterogeneity in multifocal atherosclerosis in elderly patients. Russian Journal of Preventive Medicine, 2019, vol. 22, no. 4, pp. 129-137. (In Russ.)